84 related articles for article (PubMed ID: 17671707)
1. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the expression of VEGF, EGFR, and HER-2 mRNA in esophageal squamous cell carcinoma (ESCC) and clinicopathological features of different ethnic groups in Xinjiang.
Zhang L; Wang Y; Bai G; Zhang J; Yang M; Ma X
Tumour Biol; 2015 Dec; 36(12):9277-83. PubMed ID: 26099724
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of cystatin A expression in progression of esophageal squamous cell carcinoma.
Shiba D; Terayama M; Yamada K; Hagiwara T; Oyama C; Tamura-Nakano M; Igari T; Yokoi C; Soma D; Nohara K; Yamashita S; Dohi T; Kawamura YI
Medicine (Baltimore); 2018 Apr; 97(15):e0357. PubMed ID: 29642180
[TBL] [Abstract][Full Text] [Related]
4. A disintegrin and metalloproteinase 17 mRNA and protein expression in esophageal squamous cell carcinoma, as well as its clinicopathological factors and prognosis.
Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
Mol Med Rep; 2015 Feb; 11(2):961-7. PubMed ID: 25351873
[TBL] [Abstract][Full Text] [Related]
5. Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene.
Cooper-Knock J; Zhang S; Kenna KP; Moll T; Franklin JP; Allen S; Nezhad HG; Iacoangeli A; Yacovzada NY; Eitan C; Hornstein E; Elhaik E; Celadova P; Bose D; Farhan S; Fishilevich S; Lancet D; Morrison KE; Shaw CE; Al-Chalabi A; ; Veldink JH; Kirby J; Snyder MP; Shaw PJ
Cell Rep; 2020 Dec; 33(9):108456. PubMed ID: 33264630
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer.
Godina C; Belting M; Vallon-Christersson J; Isaksson K; Bosch A; Jernström H
Sci Rep; 2024 Mar; 14(1):6675. PubMed ID: 38509243
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 protein expression as a prognostic biomarker of gastrointestinal tumours: A systematic review and meta-analysis.
Kamposioras K; Dinas PC; Barriuoso J; Trachana V; Dimas K
Eur J Clin Invest; 2023 Dec; 53(12):e14065. PubMed ID: 37497737
[TBL] [Abstract][Full Text] [Related]
8. Anticancer role of lidocaine in oral squamous cell carcinoma through IGF2BP2-mediated CAV1 stability.
Wang Z; Zhang L; Wu T; Pan X; Li L; Liu Y
Oral Dis; 2023 Dec; ():. PubMed ID: 38071190
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 promotes glioma progression and maintains its mitochondrial inhibition resistance.
Liu Y; Chen Y; Wang F; Lin J; Tan X; Chen C; Wu LL; Zhang X; Wang Y; Shi Y; Yan X; Zhao K
Discov Oncol; 2023 Aug; 14(1):161. PubMed ID: 37642765
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of Cadherins switch and Caveolin-2 during stages of oral carcinogenesis.
Nascimento RB; Machado IAR; Silva JC; Faria LAS; Borba FC; Porto LPA; Santos JN; Ramalho LMP; Rodini CO; Rodrigues MFSD; Paiva KBS; Xavier FCA
J Oral Maxillofac Pathol; 2023; 27(3):507-514. PubMed ID: 38033949
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1: A Review of Intracellular Functions, Tissue-Specific Roles, and Epithelial Tight Junction Regulation.
Dalton CM; Schlegel C; Hunter CJ
Biology (Basel); 2023 Nov; 12(11):. PubMed ID: 37998001
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of CAV1 and CAV2 in Head and Neck Squamous Cell Carcinoma.
He J; Ouyang S; Zhao Y; Liu Y; Liu Y; Zhou B; Man Q; Liu B; Wu T
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830672
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC.
Saikia M; Bhattacharyya DK; Kalita JK
SN Comput Sci; 2023; 4(2):114. PubMed ID: 36573207
[TBL] [Abstract][Full Text] [Related]
15. Involvement of caveolin-1 in skin diseases.
Takamura N; Yamaguchi Y
Front Immunol; 2022; 13():1035451. PubMed ID: 36532050
[TBL] [Abstract][Full Text] [Related]
16. Association of Caveolin-1 Expression With Prostate Cancer: A Systematic Review and Meta-Analysis.
Chen P; Zhang YL; Xue B; Xu GY
Front Oncol; 2020; 10():562774. PubMed ID: 33489874
[TBL] [Abstract][Full Text] [Related]
17. Exploring the classification of cancer cell lines from multiple omic views.
Yang X; Wen Y; Song X; He S; Bo X
PeerJ; 2020; 8():e9440. PubMed ID: 32874774
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 Expression at Metastatic Lymph Nodes Predicts Unfavorable Outcome in Patients with Oral Squamous Cell Carcinoma.
Kato K; Miyazawa H; Kobayashi H; Noguchi N; Lambert D; Kawashiri S
Pathol Oncol Res; 2020 Oct; 26(4):2105-2113. PubMed ID: 31907776
[TBL] [Abstract][Full Text] [Related]
19. miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma.
Xu J; Lv H; Zhang B; Xu F; Zhu H; Chen B; Zhu C; Shen J
J Thorac Dis; 2019 Jul; 11(7):3015-3029. PubMed ID: 31463131
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
